Altamira Therapeutics to Participate at RNA Leaders USA Congress
HAMILTON, BERMUDA , Oct. 13, 2022 (GLOBE NEWSWIRE) —
Altamira Therapeutics Ltd. (Nasdaq:CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, today announced that it will participate in-person at the RNA Leaders USA Congress being held on October 18-19, 2022 at The Colonnade Hotel in Boston, Massachusetts.
Related news for (CYTO)
- Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of Circular RNA
- Altamira Therapeutics Announces Transition from NASDAQ to OTC Markets
- altamira therapeutics provides update on nasdaq listing
- altamira therapeutics announces extended iso 13485 quality management system certification for bentrio nasal spray
- altamira therapeutics provides business update and first half 2024 financial results